Status:
UNKNOWN
Ultrasound in Psoriatic Arthritis Treatment
Lead Sponsor:
University of Cagliari
Collaborating Sponsors:
Italian Society for Rheumatology
University of Turin, Italy
Conditions:
Arthritis, Psoriatic
Ultrasonography
Eligibility:
All Genders
18+ years
Brief Summary
BACKGROUND Psoriatic arthritis (PsA) is a systemic inflammatory disease with articular and extra-articular features. Establishing the prognosis of a patient with PsA is hence important to define the t...
Detailed Description
BACKGROUND Psoriatic arthritis (PsA) is a systemic inflammatory disease with articular and extra-articular features. To date remission is considered to be the ultimate goal of therapy in PsA, however,...
Eligibility Criteria
Inclusion
- Adult \> 18 years of age with PsA (according to the CASPAR classification Criteria)
- Clinically active arthritis, with at least one joint clinically involved (both swelling and tenderness) in patient not achieving the MDA;
- Subject newly prescribed NSAIDs (monotherapy), steroid intra-articular injections (monotherapy), conventional DMARD, biologic DMARDs as indicated by the treating rheumatologist according to usual clinical practice before US acquisition;
- Stable treatment before treatment modification (6 weeks);
- Signed informed consent form;
Exclusion
- Minimal disease activity a the time of enrolment
Key Trial Info
Start Date :
February 3 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 29 2020
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03330769
Start Date
February 3 2017
End Date
February 29 2020
Last Update
April 17 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria
Cagliari, Italy, 09042
2
Local Health Unit (ASL) Rome-1, Rome-4
Roma, Italy
3
University of Turin
Torino, Italy
4
University Hospital "Santa Maria della Misericordia"
Udine, Italy